Non-specific therapeutic and prophylactic biological products against human infectious diseases (including COVID-19)

Purpose

Medications against viral (RNA and DNA type), bacterial (Gr + and Gr, extra- and intracellular), and other pathogens.

Description

The action of the medications is based on restoration of homeostasis disturbed by an infectious process of any type (gene regulation of the pool of genetic determinants that ensure the formation of a full-fledged protective response to any pathogenesis).

Three-in-one principle:

• non-specific prophylactic activity (biomask function);
• high medicinal anti-infective properties;
• fast development of long-term effective immunity.

The 4th technological paradigm.

Advantages:

• full innovation cycle;
• multifunctionality;
• absence of analogues;
• domestic technologies;
• high profitability;

Active ingredients are produced of local raw materials.
The prototypes of the medications were produced made in liquid form.

Clinical trials required.

Application area

Healthcare institutions